Home

"Thank you so much. Data about the structural changes in our patient are very clear. Really powerful technology!”

University of Turin
Prof. Dr. Alfredo Brusco - Department of Medical Sciences

"We use TLA to sequence gene fusions and other rearrangements in genes of interest. We have been impressed by the quality of TLA and Cergentis' work and are testing the use of identified breakpoint sequences as targets for personalised minimal residual disease tests."

Princess Máxima Center for Pediatric Oncology
Dr. Roland Kuiper - PI
  • Latest news

  • Empowering advanced genetic engineering
    &
    precision medicine

  • Upcoming events

    30 | 11 | 2021 / 3 | 12 | 2021 - Conferences
    Read more
  • APPNOTES

    Read more
  • TLA technology

    Read more
  • Publications

    Read more
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT